On November 22, 2013, CMS is hosting a Special Open Door Forum to discuss the design and implementation of the Medicare Intravenous Immune Globulin (IVIG) Demonstration. The purpose of the demonstration is to evaluate the impact of providing payment for items and services needed for the in-home administration of IVIG for the treatment of primary immune deficiency disease.
This article is presented for informational purposes only and is not intended to constitute legal advice.
